0001209191-24-001980.txt : 20240119
0001209191-24-001980.hdr.sgml : 20240119
20240119210411
ACCESSION NUMBER: 0001209191-24-001980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240119
FILED AS OF DATE: 20240119
DATE AS OF CHANGE: 20240119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morgan Adam
CENTRAL INDEX KEY: 0001964335
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 24546919
MAIL ADDRESS:
STREET 1: 1055B POWERS PLACE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-19
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001964335
Morgan Adam
4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2024-01-19
4
A
0
13948
0.00
A
51827
D
Common Stock
6986744
I
By Velan Capital Master Fund LP
Stock Option (Right to Buy)
2.09
2024-01-19
4
A
0
83685
0.00
A
2034-01-19
Common Stock
83685
83685
D
The shares were granted as restricted stock units which vest in full on January 19, 2025.
Securities owned directly by Velan Master. Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.
/s/ Lisa Peraza Attorney-in-fact for Adam Morgan
2024-01-19